• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-色氨酸6-促黄体生成素释放激素微胶囊长期抑制垂体治疗性早熟期间促性腺激素和α亚基的分泌

Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.

作者信息

Lahlou N, Roger M, Chaussain J L, Feinstein M C, Sultan C, Toublanc J E, Schally A V, Scholler R

机构信息

Fondation de Recherche en Hormonologie, Paris, France.

出版信息

J Clin Endocrinol Metab. 1987 Nov;65(5):946-53. doi: 10.1210/jcem-65-5-946.

DOI:10.1210/jcem-65-5-946
PMID:2959680
Abstract

Short term treatment with GnRH agonists has been reported to increase plasma gonadotropin alpha-subunit (Gn alpha) levels while decreasing plasma immunoreactive LH (IR-LH) levels. In this study we examined the effect of D-Trp6-LHRH (LHRH-A) in microcapsules (60 micrograms/kg, im, every 28 days for 1 yr) in 13 girls suffering from precocious puberty. Plasma IR-Gn alpha was measured by RIA; plasma IR-LH and IR-FSH were measured by both polyclonal RIAs and monoclonal immunoradiometric assays (IRMA). Before treatment, basal IR-LH and IR-FSH levels and peak responses to LHRH measured by both RIA and IRMA were similar, and the Gn alpha response paralleled that of LH. After the first injection of LHRH-A, RIA LH levels were significantly higher than pretreatment levels until day 21, while IRMA LH levels transiently increased, but returned to pretreatment levels by day 7 and became lower thereafter (P less than 0.005). Plasma IR-Gn alpha levels increased from days 3-21 (P less than 0.05). After 1.5 months of treatment, basal RIA LH levels remained detectable and not different from pretreatment levels; IRMA LH levels were very low. The mean RIA and IRMA LH responses to LHRH were decreased at 1.5 and 12 months (P less than 0.01). Basal plasma RIA and IRMA FSH levels were similar during treatment (P greater than 0.05) and significantly lower than pretreatment values (P less than 0.01). The mean RIA and IRMA FSH responses to LHRH decreased significantly at 1.5 months (P less than 0.001). After 12 months, both RIA and IRMA FSH responses were increased, but IRMA values were significantly lower than RIA values. A sustained increase in basal Gn alpha values occurred, but there was a tendency for the peak levels after LHRH treatment to decrease, becoming significantly lower than pretreatment peak levels after 1 yr. The chromatographic analysis on Sephadex G-100 of a pool of plasma samples collected during a LHRH test in three children treated for 6 months indicated that IR-Gn alpha coeluted with [125I]Gn alpha. The large discrepancy between RIA and IRMA LH values suggests the secretion of unusual LH molecules which are recognized by RIA but not by IRMA. The sustained release of large amounts of IR-Gn alpha indicates dissociated effects of LHRH-A on alpha- and beta-subunit secretion by the gonadotrophs. The sustained response of Gn alpha to LHRH demonstrates that gonadotroph cell LHRH receptors are still responsive to LHRH during treatment with a LHRH agonist.

摘要

据报道,用促性腺激素释放激素(GnRH)激动剂进行短期治疗可使血浆促性腺激素α亚基(Gnα)水平升高,同时使血浆免疫反应性促黄体生成素(IR-LH)水平降低。在本研究中,我们检测了微囊化的D-色氨酸6-促黄体生成素释放激素(LHRH-A)(60微克/千克,肌肉注射,每28天一次,共1年)对13名性早熟女孩的影响。用放射免疫分析法(RIA)测定血浆IR-Gnα;用多克隆RIA和单克隆免疫放射测定法(IRMA)测定血浆IR-LH和IR-FSH。治疗前,通过RIA和IRMA测得的基础IR-LH和IR-FSH水平以及对LHRH的峰值反应相似,Gnα反应与LH反应平行。首次注射LHRH-A后,直到第21天,RIA LH水平显著高于治疗前水平,而IRMA LH水平短暂升高,但在第7天恢复到治疗前水平,此后变得更低(P<0.005)。血浆IR-Gnα水平在第3至21天升高(P<0.05)。治疗1.5个月后,基础RIA LH水平仍可检测到,且与治疗前水平无差异;IRMA LH水平非常低。在1.5个月和12个月时,对LHRH的平均RIA和IRMA LH反应降低(P<0.01)。治疗期间基础血浆RIA和IRMA FSH水平相似(P>0.05),且显著低于治疗前值(P<0.01)。在1.5个月时,对LHRH的平均RIA和IRMA FSH反应显著降低(P<0.001)。1

相似文献

1
Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.D-色氨酸6-促黄体生成素释放激素微胶囊长期抑制垂体治疗性早熟期间促性腺激素和α亚基的分泌
J Clin Endocrinol Metab. 1987 Nov;65(5):946-53. doi: 10.1210/jcem-65-5-946.
2
Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.通过定期给予长效D-色氨酸6-促黄体生成素释放激素微胶囊制剂对男性和女性性早熟进行长期治疗。
J Clin Endocrinol Metab. 1986 Apr;62(4):670-7. doi: 10.1210/jcem-62-4-670.
3
Effect of deslorelin dose in the treatment of central precocious puberty.地洛瑞林剂量对中枢性性早熟治疗的影响。
J Clin Endocrinol Metab. 1991 Jan;72(1):60-4. doi: 10.1210/jcem-72-1-60.
4
The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.促黄体生成素释放激素(LHRH)激动剂[D-色氨酸6-脯氨酸9-乙基]LHRH在一名分泌促黄体生成素(LH)的垂体肿瘤患者中升高而非降低了LH和α亚基水平。
J Clin Endocrinol Metab. 1984 Feb;58(2):313-9. doi: 10.1210/jcem-58-2-313.
5
Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.促性腺激素释放激素激动剂在两名分泌促性腺激素的垂体腺瘤患者中未能成功降低肿瘤促性腺激素的分泌。
J Clin Endocrinol Metab. 1988 Jul;67(1):180-5. doi: 10.1210/jcem-67-1-180.
6
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.促性腺激素和α亚基对糖蛋白激素分泌型垂体瘤患者长期给予促性腺激素释放激素类似物的反应。
J Clin Endocrinol Metab. 1989 Jan;68(1):81-6. doi: 10.1210/jcem-68-1-81.
7
Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.中枢性性早熟长期使用促黄体生成素释放激素激动剂治疗后青春期的恢复
J Clin Endocrinol Metab. 1988 Aug;67(2):368-72. doi: 10.1210/jcem-67-2-368.
8
Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.用强效促黄体生成素释放因子激动剂治疗真性性早熟:对生长、性成熟、盆腔超声检查及下丘脑-垂体-性腺轴的影响。
J Clin Endocrinol Metab. 1985 Jul;61(1):142-51. doi: 10.1210/jcem-61-1-142.
9
Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.性早熟乳房过早发育与中枢性性早熟:临床表现与促性腺激素对促黄体生成素释放激素反应之间的关系
J Clin Endocrinol Metab. 1988 Sep;67(3):474-9. doi: 10.1210/jcem-67-3-474.
10
Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.性早熟女童停用促性腺激素释放激素类似物治疗后的生殖轴:下丘脑错构瘤女童与特发性性早熟女童的长期随访比较
J Clin Endocrinol Metab. 1999 Jan;84(1):44-9. doi: 10.1210/jcem.84.1.5409.

引用本文的文献

1
Update on bioethical, medical and fertility issues in gender incongruence during transition age.青春期性别认同障碍的生物伦理、医学和生育问题的最新进展。
J Endocrinol Invest. 2023 Sep;46(9):1725-1736. doi: 10.1007/s40618-023-02077-5. Epub 2023 Apr 18.
2
Characterization of the EM66 Biomarker in the Pituitary and Plasma of Healthy Subjects With Different Gonadotroph Status and Patients With Gonadotroph Tumor.不同促性腺激素状态健康受试者及促性腺激素瘤患者垂体和血浆中EM66生物标志物的特征分析
Front Endocrinol (Lausanne). 2019 Feb 22;10:102. doi: 10.3389/fendo.2019.00102. eCollection 2019.
3
Characterization of 12 GnRH peptide agonists - a kinetic perspective.
12种促性腺激素释放激素(GnRH)肽激动剂的特性——动力学视角
Br J Pharmacol. 2016 Jan;173(1):128-41. doi: 10.1111/bph.13342. Epub 2015 Nov 4.
4
Current and future applications of GnRH, kisspeptin and neurokinin B analogues.GnRH、kisspeptin 和神经激肽 B 类似物的当前和未来应用。
Nat Rev Endocrinol. 2013 Aug;9(8):451-66. doi: 10.1038/nrendo.2013.120. Epub 2013 Jul 2.
5
Decoding high Gonadotropin-releasing hormone pulsatility: a role for GnRH receptor coupling to the cAMP pathway?解析高促性腺激素释放激素脉冲性:促性腺激素释放激素受体与 cAMP 通路偶联的作用?
Front Endocrinol (Lausanne). 2012 Aug 31;3:107. doi: 10.3389/fendo.2012.00107. eCollection 2012.
6
Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.促黄体生成激素释放激素(LHRH)激动剂曲普瑞林和LHRH拮抗剂西曲瑞克长期治疗对大鼠垂体LHRH受体水平及其mRNA表达的影响。
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15048-53. doi: 10.1073/pnas.232579499. Epub 2002 Oct 30.
7
Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.促性腺激素细胞腺瘤患者对促性腺激素释放激素激动剂和拮抗剂给药的反应。
J Endocrinol Invest. 1994 Feb;17(2):91-8. doi: 10.1007/BF03347692.
8
Clinical applications of GnRH analogs.促性腺激素释放激素类似物的临床应用。
J Endocrinol Invest. 1988 Nov;11(10):745-54. doi: 10.1007/BF03350939.
9
Dissociated effect of buserelin on luteinizing hormone (LH) and alpha subunit in men.布舍瑞林对男性促黄体生成素(LH)和α亚基的解离作用。
J Endocrinol Invest. 1990 Jun;13(6):459-67. doi: 10.1007/BF03348599.